Tradestie Institutional Equity Comparison Engine

ENSC vs FRMM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ENSC Overall Edge

ENSC Captures Institutional Edge (3โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ensysce Biosciences, Inc. Common Stock (ENSC) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, ENSC trades at 0.8x Forward P/E with -281.3% operating margin (-15.1% YoY revenue) versus FRMM at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ENSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against FRMM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ENSC
ENSC 0.8x vs FRMM N/M Fwd P/E
Growth & Margin Winner ENSC
Op Margin -281.3% vs N/A ยท YoY -15.1% vs N/A
Momentum & Technical Winner ENSC
1Y -80.3% vs -44.5% ยท 52W Pos 8% vs 3%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ENSC NASDAQ
Ensysce Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$0.36
-0.17% 1D
Market Cap $7.0M
1M Return -29.55%
1Y Return -80.33%
Forward P/E 0.8x
Unified AI Score
53.4 / 100 HOLD
Tech 50.0 Fund 62.0 Flow 50.0 Mom 60.0
FRMM US Equity
FRMM
Institutional Equity
$1.92
-4.48% 1D
Market Cap N/A
1M Return -42.34%
1Y Return -44.51%
Forward P/E N/M
Unified AI Score
42.5 / 100 HOLD
Tech 35.0 Fund 44.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ENSC -80.33% FRMM -44.51% Spread: +4.51 pp (ENSC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ENSC TTM Op. Margin: -281.3% FRMM TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ENSC vs FRMM. Trailing 12-month operating profitability (ENSC -281.3% vs FRMM N/A) and valuation multiples (ENSC 0.8x vs FRMM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ENSC (10) vs FRMM (0)
Institutional Metric ENSC FRMM Criterion Row Winner
Market Capitalization Scale $7.0M N/A Larger Scale ENSC
Trailing P/E Ratio Valuation 0.8x N/M Lower Multiple ENSC
Forward P/E Ratio Valuation 0.8x N/M Lower Multiple ENSC
Revenue Growth (YoY) Growth -15.1% N/A Higher Growth ENSC
Operating Margin (TTM) Profitability -281.3% N/A Higher Margin ENSC
Net Profit Margin Profitability -280.5% N/A Higher Margin ENSC
Return on Equity (ROE) Capital Efficiency -1295.1% N/A Higher ROE ENSC
52-Week Range Position Momentum 8% ($0โ€“$2) 3% ($2โ€“$7) Stronger Trend ENSC
Beta / 30D Volatility Risk Regime 0.98ฮฒ ยท 79% Vol 2.28ฮฒ ยท 107% Vol Lower Realized Risk ENSC
Unified Institutional Score Composite Signal 53.4 / 100 (HOLD) 42.5 / 100 (HOLD) Higher Composite ENSC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ENSC vs FRMM Buy Guide
ENSC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ENSC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FRMM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live FRMM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ENSC nor FRMM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.